Wegovy (semaglutide) and phentermine are both FDA-approved weight-loss medicines, but they sit at opposite ends of the spectrum. Wegovy is a newer, expensive, long-term treatment that produces about 15% average weight loss and lowers heart risk. Phentermine is an old, cheap stimulant approved for short-term use that typically produces around 5% weight loss beyond placebo.
- Effectiveness: Wegovy 2.4 mg led to about 15% average weight loss over 68 weeks in the STEP 1 trial. Phentermine alone typically leads to 3 to 8 kg over 12 to 24 weeks. Phentermine combined with topiramate (Qsymia) reaches about 9% to 10%.
- How long you can use them: Wegovy is approved for long-term use. Phentermine is labeled for short-term use, a few weeks (usually up to 12), though doctors sometimes prescribe it longer off-label.
- Extra benefits: Wegovy is approved to cut the risk of heart attack, stroke and cardiovascular death in adults with heart disease and overweight or obesity, and to treat the liver disease MASH. Phentermine has no such benefits.
- Safety trade-offs: Wegovy mainly causes stomach side effects. Phentermine raises heart rate and blood pressure, can disturb sleep, and is a Schedule IV controlled substance.
- Cost: generic phentermine usually costs a few dollars to tens of dollars a month. Wegovy costs hundreds of dollars or more without coverage.
This is general information, not medical advice. Choosing a weight-loss medicine depends on your health, other medicines, goals and coverage. Talk to a clinician experienced in obesity treatment.
Wegovy vs phentermine at a glance
| Wegovy (semaglutide) | Phentermine | |
|---|---|---|
| Approved | 2021 (weight management) | 1959 |
| Drug class | GLP-1 receptor agonist | Sympathomimetic amine (stimulant) |
| Form | Weekly injection (2.4 mg, or 7.2 mg as Wegovy HD) or daily 25 mg tablet | Daily tablet or capsule (8 to 37.5 mg) |
| Approved duration | Long term | Short term (a few weeks) |
| Average weight loss | About 15% | About 5% beyond placebo |
| Heart risk reduction | Yes (SELECT trial) | No; caution in heart disease |
| Controlled substance | No | Yes (Schedule IV) |
| Ages | Adults; adolescents 12+ (injection) | Adults and adolescents over 16 |
| Typical monthly cost without insurance | High | Low (generic) |
How they work
Wegovy copies GLP-1, a gut hormone that signals fullness, slows stomach emptying and dampens appetite and food cravings through the brain. Many people describe “food noise” quieting down. Because the effect is driven by satiety rather than stimulation, energy levels are not raised.
Phentermine releases noradrenaline in the brain, suppressing appetite much as a mild amphetamine would. It also raises alertness, which is why it can cause jitteriness and insomnia, and why it is taken in the morning.
Dosing
Wegovy
- Injection: start at 0.25 mg weekly and increase every 4 weeks (0.5, 1, 1.7 mg) to the 2.4 mg maintenance dose from week 17. Since March 2026, adults may move up to 7.2 mg weekly (Wegovy HD) for more weight loss.
- Tablet: start at 1.5 mg daily for 30 days, then 4 mg, 9 mg and the 25 mg maintenance dose, each for 30 days. Take on an empty stomach with a small sip of water, 30 minutes before eating.
Phentermine
- 37.5 mg once daily before breakfast or 1 to 2 hours after breakfast is the most common dose. Some people take half a tablet.
- Lomaira (8 mg) can be taken up to three times daily, 30 minutes before meals.
- Doses should be as low as needed, and late-day doses avoided because of insomnia.
How much weight do people lose?
| Treatment | Typical average weight loss | Evidence |
|---|---|---|
| Wegovy 2.4 mg weekly | About 15% at 68 weeks | STEP 1 (1,961 adults) |
| Wegovy 7.2 mg weekly (Wegovy HD) | More than 2.4 mg | STEP UP trials |
| Wegovy 25 mg tablet | About 14% at 64 weeks (about 2% on placebo) | OASIS 4 trial |
| Phentermine alone | Around 5% beyond placebo over 3 to 6 months | Older, short trials |
| Phentermine plus topiramate (Qsymia), top dose | About 9% to 10% at 1 year | CONQUER and EQUIP trials |
Wegovy’s advantage holds up well over time, while phentermine’s effect often fades after several months as tolerance develops.
Benefits beyond weight
Wegovy
- Heart protection: in SELECT, 17,604 adults with established cardiovascular disease and overweight or obesity (no diabetes) had a 20% lower risk of heart attack, stroke or cardiovascular death on semaglutide 2.4 mg compared with placebo.
- Liver: accelerated FDA approval in August 2025 for MASH with moderate to advanced scarring (injection only).
- Blood sugar, blood pressure and cholesterol all tend to improve.
Phentermine
- Weight loss itself improves blood pressure, blood sugar and cholesterol, but phentermine’s own stimulant effect can push blood pressure and heart rate up, which partly offsets that.
Side effects
| Side effect | Wegovy | Phentermine |
|---|---|---|
| Nausea, vomiting, diarrhea | Very common | Uncommon |
| Constipation | Common | Common |
| Dry mouth | Occasional | Very common |
| Insomnia | Rare | Common |
| Raised heart rate | Small increase | Common |
| Raised blood pressure | Usually falls with weight loss | Can rise |
| Anxiety, restlessness | Uncommon | Common |
| Gallbladder problems | Increased risk | Not typical |
| Pancreatitis | Rare but serious | Not typical |
| Misuse or dependence | No | Possible |
Wegovy also carries a boxed warning about thyroid C-cell tumors seen in rodents, and warnings about kidney injury from dehydration, severe stomach problems, diabetic eye disease, and aspiration during anesthesia. At the 7.2 mg dose, altered skin sensation (tingling or burning) was more common.
Phentermine has rare but serious risks of primary pulmonary hypertension and heart valve disease. Stop it and seek care for new breathlessness, chest pain, fainting or swollen ankles.
Who should not use them
Phentermine is not suitable if you have
- heart disease, a history of stroke, arrhythmias, heart failure or uncontrolled high blood pressure
- hyperthyroidism
- glaucoma
- a history of drug misuse or agitation
- recent use of MAO inhibitors (within 14 days)
- pregnancy or breastfeeding
Wegovy is not suitable if you have
- a personal or family history of medullary thyroid carcinoma, or MEN 2
- a previous serious allergic reaction to semaglutide
- pregnancy, or plans to conceive within 2 months
Can you take Wegovy and phentermine together?
Some clinicians prescribe them together off-label for people who plateau, but the combination isn’t FDA-approved and hasn’t been tested in large trials. Both suppress appetite, and side effects such as poor intake, dehydration, constipation and a faster heart rate can add up. Read more in our guide to Ozempic vs phentermine and taking them together.
What happens when you stop?
Weight regain is common after stopping either drug. After stopping semaglutide in the STEP 1 extension, people regained about two-thirds of the lost weight within a year. Phentermine is usually stopped after a short course by design, so long-term success depends on the habits built alongside it. Obesity medicines generally work best as part of a long-term plan that includes nutrition, activity, sleep and, for some people, behavioral support.
Cost and access
- Phentermine: generic and inexpensive. It’s a controlled substance, so prescriptions have refill limits, and some states have extra rules.
- Wegovy: list price is high. Coverage for obesity varies by insurer. Medicare can cover it for its cardiovascular-risk indication in eligible people. Novo Nordisk offers savings programs and cash-pay options.
- Avoid unapproved sources. The FDA has warned about counterfeit and unapproved semaglutide products sold online.
Which might suit you?
| Situation | More suitable option |
|---|---|
| You want the largest, longest-lasting weight loss | Wegovy (or Zepbound) |
| Heart disease, or high cardiovascular risk | Wegovy; avoid phentermine |
| Budget is the main constraint, short course planned | Phentermine (if no heart issues) |
| Need a long-term oral option | Wegovy tablet or Qsymia |
| Anxiety, insomnia or stimulant sensitivity | Wegovy |
| Strong nausea or gastrointestinal disease | Discuss carefully; phentermine or other options may suit better |
Frequently asked questions
Is Wegovy better than phentermine?
For most people it produces much more weight loss (about 15% vs around 5% beyond placebo) and is approved for long-term use and heart risk reduction. Phentermine’s advantages are low cost and a pill form, but it is meant for short-term use and is not suitable for people with heart disease.
How much weight can you lose on phentermine?
Typically 3 to 8 kg over 12 to 24 weeks, roughly 5% of body weight beyond placebo. Results vary, and the effect often fades after a few months.
Can you take phentermine and Wegovy at the same time?
Some doctors prescribe them together off-label, but the combination isn’t FDA-approved or well studied. Side effects such as poor appetite, dehydration and raised heart rate can add up, so it requires close supervision.
Is phentermine safe long term?
Phentermine is labeled for short-term use. Some doctors prescribe it for longer with monitoring of blood pressure and heart rate, but long-term safety data are limited. Qsymia, which combines phentermine with topiramate, is approved for long-term use.
Is there a Wegovy pill?
Yes. Wegovy tablets (oral semaglutide 25 mg once daily) are approved for weight management and heart risk reduction in adults.
Which is cheaper, phentermine or Wegovy?
Phentermine, by a wide margin. Generic phentermine usually costs little; Wegovy is a brand-name drug with a high list price, although insurance and savings programs can lower the cost.
References
- FDA. WEGOVY (semaglutide) injection and tablets prescribing information, revised 2026
- DailyMed. Phentermine hydrochloride label
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389:2221-2232
- Gadde KM, et al. Phentermine plus topiramate (CONQUER). Lancet. 2011;377:1341-1352
- VA Pharmacy Benefits Management. Oral semaglutide (Wegovy) for weight management monograph, March 2026
- FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss
Try our interactive tool: GLP-1 weight loss drug comparison tool
Compare Zepbound, Wegovy, the Wegovy pill, Foundayo and Saxenda side by side.
About this article
Written by the Health Linear Editorial Team from primary sources such as FDA prescribing information, DailyMed, NIH and peer-reviewed studies, which are linked in the article. Last updated October 30, 2026.
Read our editorial process and medical disclaimer. Spotted an error? Tell us and we will correct it.